Today, @Elise__Jenkins and I are thrilled to announce our $10m seed round. Coherence Neuro is building foundational neurotechnology that will overhaul how we track and treat cancer. 40% of us will get cancer in our lifetimes, yet there is no single cancer care company. Why? Because the entire process involves numerous moving parts, various approaches, medications, and monitoring techniques, with no unified whole. We solve this through our therapeutic neurotechnology and BCI platform—a critical technology for extending life and improving the human condition. Our platform brings a new approach to treating the disease while capturing biological data that was previously impossible to harness. Combining these breakthroughs with AI, we can build cancer prediction models that update in real-time. We’ll adapt stimulation and drug therapies with continuous feedback to guarantee the most effective course of treatment. All this begins with a tiny implant that treats cancer with electricity via your body’s master control system—the nervous system. Our round was led by @topology_vc (@caseykcaruso) and @artesianvc , with continued support from all our pre-seed investors @Blackbird (@michaelatolo), @PossibleVC, and joined by investors and angels, @XEIA (@samalanascience & @therealbrom), @akilian, @arminbuilds, @mattkrisiloff , @lintaho, @timshi_ai, and @tszzl